Data processing: measuring – calibrating – or testing – Measurement system in a specific environment – Biological or biochemical
Reexamination Certificate
2011-02-22
2011-02-22
Moran, Marjorie (Department: 1631)
Data processing: measuring, calibrating, or testing
Measurement system in a specific environment
Biological or biochemical
C702S027000, C530S326000
Reexamination Certificate
active
07894999
ABSTRACT:
The present invention provides a new class of peptides related to rapid replication and high human mortality, and their use in diagnosing, preventing and treating disease including vaccines and therapeutics for emerging viral diseases and methods of identifying the new class of peptides and related structures.
REFERENCES:
patent: 5104854 (1992-04-01), Schlesinger et al.
patent: 5231167 (1993-07-01), Zanetti
patent: 5280113 (1994-01-01), Rademacher
patent: 5679352 (1997-10-01), Chong
patent: 5866690 (1999-02-01), Bogoch
patent: 6023659 (2000-02-01), Seilhamer
patent: 6070126 (2000-05-01), Kokolus
patent: 6090406 (2000-07-01), Popescu et al.
patent: 6242578 (2001-06-01), Bogoch
patent: 6256647 (2001-07-01), Toh
patent: 6470277 (2002-10-01), Chin
patent: 6484166 (2002-11-01), Maynard
patent: 6638505 (2003-10-01), Bogoch
patent: 7189800 (2007-03-01), Bogoch et al.
patent: 7267942 (2007-09-01), Peiris
patent: 2002/0120106 (2002-08-01), Bogoch
patent: 2002/0151677 (2002-10-01), Bogoch
patent: 2003/0180328 (2003-09-01), Bogoch
patent: 2003/0194414 (2003-10-01), Bogoch
patent: 2005/0129715 (2005-06-01), Paterson et al.
patent: 2005/0202415 (2005-09-01), Bogoch
patent: 2005/0271676 (2005-12-01), Sette et al.
patent: 2006/0024669 (2006-02-01), Bogoch
patent: 2007/0128217 (2007-06-01), ter Meulen et al.
patent: 3628658 (1988-03-01), None
patent: 0 108 564 (1984-05-01), None
patent: 98MI0874 (1999-10-01), None
patent: 3-503166 (1991-07-01), None
patent: 10-212300 (1998-08-01), None
patent: 11001493 (1999-01-01), None
patent: 11001493 (1999-01-01), None
patent: 2000-253876 (2000-09-01), None
patent: 8907112 (1989-10-01), None
patent: 96/32106 (1996-10-01), None
patent: 0018351 (2000-04-01), None
patent: 0104135 (2001-01-01), None
patent: 02085093 (2002-10-01), None
patent: 03005880 (2003-01-01), None
patent: 03083058 (2003-10-01), None
patent: 2005010032 (2005-02-01), None
patent: 2005004754 (2005-11-01), None
Atassi, M. Z. et al., “A novel approach for localization of the continuous protein antigenic sites by comprehensive synthetic surface scanning: Antibody and T cell activity to several influenza hemagglutinin synthetic sites,” Immunological Communications, 1984, pp. 539-551, vol. 13, No. 6, Marcel Dekker, Inc., XP009062995, ISSN: 0090-0877.
Brown, L. R. et al., “Recognition of the influenza hemagglutinin by Class II MHC-restricted T lymphocytes and antibodies,” Journal of Immunology, Oct. 15, 1991, pp. 2677-2684, vol. 147, No. 8, American Association of Immunologists, USA, XP002371257, ISSN: 0022-1767.
Ben-Yedidia, T. et al., “Intranasal administration of peptide vaccine protects human/mouse radiation chimera from influenza infection,” International Immunology, 1999, pp. 1043-1051, XP000914818, ISSN: 0953-8178.
Bogoch, S, et al., “Rapid replication and Replikintm structures: basis of the AMASRTest and CAVAXR,” Cancer Detection and Prevention Online, Feb. 9, 2002, XP002350483.
Brumeanu, T.D. et al., “Immunogenicity of a Contiguous T-B Synthetic Epitope of the A/PR/8/34 Infuenza Virus,” Journal of Virology, Jul. 1997, vol. 71, No. 7, pp. 5473-5480.
Carr, C. M. et al., “A spring-loaded mechanism for the conformational change of influenza hemagglutinin,” Cell, May 21, 1993, pp. 823-832, vol. 73, Cell Press, XP002059698, ISSN: 0092-8674.
Chambers, T.M. et al., “Antigenic and molecular characterization of subtype H13 hemagglutinin of influenza virus,” Database NCBI on STN, Accession No. HMIVT2, Virology, pp. 180-188, abstract, 1989, 172(1).
Gelder, CM et al. “Human CD4+ T-cell repertoire of response to influenza A virus hemagglutinin after recent natural infection,” Journal of Virology, Dec. 1995, vol. 69, No. 12, pp. 7497-7506A.
O'Donnell, F.T. et al., “Epidemiology and molecular characterization of co-circulating influenza A/H3N2 virus variants in children,” Epidemiology and Infection, Jun. 2003, pp. 521-531, abstract, vol. 130, issue 3, The University of Texas-Houston School of Public Health, Houston, Texas.
Orlando, C. et al., “A monoclonal antibody directed against the catalytic site of Bacillus anthracis adenylyl cyclase identifies a novel mammalian brain catalytic subunit,” Biochemistry, 1992, pp. 3215-3222, vol. 31, American Chemical Society, XP002371438, ISSN: 0006-2960.
Schenk, S. et al., “Four recombinant isoforms of Cor a 1, the major allergen of hazel pollen, show different reactivities with allergen-specific T-lymphocyte clones,” European Journal of Biochemistry, 1994, pp. 717-722, vol. 224, XP002371408, ISSN: 0014-2956.
Marra, m. et al., “The Genome Sequence of the SARS-Associated Coronavirus,” Science, American Association for the Advancement of Science, US, v. 300, No. 5624, p. 1399-1404, XP002269483, ISSN: 0036-8075, May 30 2003.
Qin, E. et al., “A Genome Sequence of Novel SARS-CoV Isolates: the Genotype, GD-Ins29, Leads to a Hypothesis of Viral Transmission in South China,” Genomics Proteomics & Bioinformatics, vol. 1, No. 2, p. 101-107, XP001206098, ISSN: 1672-0229, May 2003.
Rota, P. et al., “Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome,” Science, American Association for the Advancement of Science, US, v. 300, No. 5624, p. 1394-1399, XP002269482, ISSN: 0036-8075, May 30 2003.
Tanaka, T. et al., “Efficient Generation of Antibodies to Oncoporteins by using Synthetic Peptide Antigens.” Proceedings of the National Academy of Sciences of USA, National Academy of Science, Washington, D.C., US, v. 82, No. 10, p. 3400-3404, tables 1, Peptide 21, XP000113798, ISSN: 0027-8424, May 1 1985.
Gao et al., Identification and characterization of T helper epitopes in the nucleoprotein of influenza A virus, J Immunol. Nov. 1, 1989, vol. 143, No. 9, pp. 3007-3014, see Figure 1, first line, right hand side sequence (ERR . . . ), 3008, col. 1, Viruses and Other Ag and Immunization.
Shi et al., Immunogenicity and in vitro protective efficacy of a recombinant multistage Plasmodium falciparum candidate vaccine. Proc. Nat'l. Acad. Sci., USA. Feb. 1999, vol. 96, No. 4, pp. 1615-1620, see Table 1 and p. 1616, Materials and Methods.
Bogoch, S. et al., “A Checklist for Suitability of Biomarkers as Surrogate Endpoints in Chemoprevention of Breast Cancer,” Journal of Cellular Biochemistry, Supplement, Boston, US, vol. 19, pp. 173-185, XP009046492, ISSN: 0733-1959, 1994.
PCT International Search Report and Written Opinion, PCT/US2007/069978, Jun. 3, 2008, EPO, International Searching Authority, Rijswijk, NL.
PCT International Search Report and Written Opinion, PCT/US2007/82436, Jan. 9, 2009, USPTO, International Searching Authority, Alexandria, VA, USA.
PCT International Search Report and Written Opinion, PCT/US2008/00645, Feb. 2, 2009, USPTO, International Searching Authority, Alexandria, VA, USA.
PCT International Search Report and Written Opinion, PCT/US2008/061336, Feb. 2, 2009, EPO, International Searching Authority, Rijswijk, NL.
Witteveldt, et al., “Protection of Penaeus monodon against White Spot Syndrome Virus by oral Vaccination,” Journal of Virology, Feb. 2004, p. 2057-2061 vol. 78, No. 4, entire document, esp. p. 2060, col. 1.
Bogoch et al., “Replikins: The Chemistry of Rapid Replication,” Begell House, Inc., NY, NY (2005).
PCT International Preliminary Report on Patentability, PCT/US2007/069978, May 1, 2009, USPTO, International Preliminary Examining Authority, Alexandria, VA, USA.
EP Office Action 04785929.3, Feb. 2, 2009, EPO, Netherlands.
NZ Office Action 560415, Mar. 6, 2009, IPO, New Zealand.
UnitProt/Swiss-Prot database entry O89746 1 Influenza A virus (strain A/Chicken/Hong Kong/220/1997 H5N1 genotype Gs/Gd) dated Nov. 1, 1998.
Patil et al., “Identification of a Talin-binding Site in the Integrin β3 Subunit Distinct from the NPLY Regulatory Motif of a Post-ligand Binding Functions,” The Journal of Biological Chemistry, vol. 274, No. 1, Oct. 1, 1999, p. 28575-28583.
Bogoch Elenore S.
Bogoch Samuel
Bogoch Samuel Winston
Borsanyi Anne-Elenore Bogoch
Kenyon & Kenyon LLP
Moran Marjorie
Sims Jason M
LandOfFree
Systems and methods for identifying Replikin Scaffolds and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Systems and methods for identifying Replikin Scaffolds and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Systems and methods for identifying Replikin Scaffolds and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2630583